Rotenone inhibits primary murine myotube formation via Raf-1 and ROCK2

Sander Grefte1, Jori A L Wagenaars1, Renate Jansen1

  • 1Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Insights

Rotenone specifically inhibits myotube formation by affecting the Raf-1/ROCK2 pathway, independent of its impact on mitochondrial complex I. This finding offers new insights into rotenone

Area of Science:

  • Mitochondrial biology and cellular respiration
  • Muscle development and differentiation

Background:

  • Rotenone (ROT) is a common inhibitor of mitochondrial complex I (CI) in the oxidative phosphorylation (OXPHOS) system.
  • ROT can exhibit off-target effects, particularly at higher concentrations, necessitating investigation into its precise mechanisms of action.

Purpose of the Study:

  • To investigate the specific effects of rotenone on in vitro primary murine myotube formation.
  • To elucidate the molecular pathways involved in rotenone-induced inhibition of myogenesis.

Main Methods:

  • Treatment of primary murine myotubes with rotenone (ROT) and piericidin A (PA).
  • Assessment of myotube formation and myoblast oxygen consumption.
  • Gene knockdown experiments targeting ROCK1, ROCK2, and RhoA, along with inhibition of Raf-1 activity.

Main Results:

  • ROT (10-100nM) specifically inhibited myotube formation, unlike piericidin A (PA).
  • Both ROT and PA blocked oxygen consumption at 100nM.
  • ROCK2 knockdown, and to a lesser extent ROCK1, prevented ROT-induced inhibition, which was reversed by inhibiting Raf-1 activity.
  • RhoA knockdown did not prevent ROT-induced inhibition of myotube formation.

Conclusions:

  • Rotenone inhibits primary myotube formation through a mechanism independent of its effect on Complex I-driven mitochondrial ATP production.
  • The Raf-1/ROCK2 pathway is critically involved in rotenone's inhibitory effects on myogenesis.
  • These findings highlight specific off-target effects of rotenone in muscle cell differentiation.

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
7.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K